"We are extremely happy to receive this award and look forward to continuing to spread Swedish innovation around the world together with Swecare, an organization doing a fantastic job for Sweden and Swedish export," says Truls Sjöstedt, Brighter's CEO and founder.

The jury's motivation reads:

"One of the major emerging health challenges that we are currently facing is diabetes, a demanding condition that can lead to serious health complications if poorly handled, resulting in not only personal suffering but also putting an enormous burden on healthcare systems. One of the biggest challenges is getting the patients to follow their treatment recommendations. 2018 was a breakthrough year for Brighter AB, which has developed a unique solution for insulin-treated diabetics; Actiste. Actiste is the world's first solution that gathers all the functions required for the monitoring and treatment of insulin-treated diabetes in a single unit. The company recently had its first commercial breakthrough in the Middle East through their subsidiary in Dubai, where they are currently undergoing discussions with the decision-making authorities regarding a national rollout of the company's diabetes solution. In addition to the Middle East, the company has also succeeded in establishing itself on the large Indonesian market, from where they in the coming years plan to move on to the rest of Southeast Asia. After several years of product development, the success is based on long-term strategic partnerships and new operational collaborations. Brighter is an active member of Swecare and uses the network and our activities for their internationalization efforts, but is also contributing with own ideas and initiatives resulting in positive dynamics and development. It's impressive to see Brighter succeeding in establishing strategic partnerships in large markets far from Sweden while still being a fairly small company. Expectations are high on Brighter and the jury is convinced that this will be become a great export success going forward."

About the Swecare Rising Star Award
Swecare Rising Star Award was established in conjunction with Swecare's 40th anniversary in 2018. The award is aimed at members that, with small means and great involvement are active in the network and contribute to the development of the organisation by sharing their successes and failures, they stand at the beginning of their internationalization efforts and are able to demonstrate that they have succeeded in putting themselves on the map. The prize will go to a real `fighter' that excelled during the past year and a company which we predict will reach substantial success globally.

For further information, please contact:
Rasmus Karlgren, Media & Communications Manager
Phone: +4672 999 38 64
Email: rasmus.karlgren@brighter.se

About Actiste.
Brighter's solution Actiste® handles most of the self-monitoring and treatment of insulin-treated diabetes in a single easy-to-use device. Measurement of glucose levels, insulin injections, automatic logging, and timing of all activities are performed from a single unit. Actiste is connected via an autonomous and secure mobile connection, and information can be automatically shared with selected recipients through The Benefit Loop®, Brighter's open cloud-based service where data is collected, processed and analyzed with patient consent.

Validated user-generated data, such as glucose levels or insulin doses, can be automatically transferred electronically to many different constituents. The patient selects when and how data is shared and who will have access to it. Through The Benefit Loop, different services can motivate patients with chronic illnesses to change their behavior, which can save lives, reduce relatives' concerns, and release enormous healthcare resources. https://actiste.com/

About Brighter AB (publ).
Brighter is a Swedish-based company that, from a unique IP portfolio, creates smart solutions for one of healthcare's biggest challenges: changing patient behavior. Chronic diseases such as diabetes are rapidly increasing, and account for an increasing share of healthcare costs globally. Brighter's Business Model and Multi-Sided Market Platform - The Benefit Loop® - is based on the fact that many special interests create value for each other. By increasing access to valid health data, Brighter creates value for all stakeholders in the care chain: patients and their close associates, healthcare providers, research institutes, the pharmaceutical industry, and society as a whole. https://brighter.se/

The Company's shares are listed on NASDAQOMX First North/BRIG (http://www.nasdaqomxnordic.com/shares/microsite?Instrument=SSE86375). Brighter's Certified Adviser on Nasdaq OMX First North is Eminova Fondkommission AB, +46 (0)8 - 684 211 00, info@eminova.se, www.eminova.se.